Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Kura Oncology (NQ: KURA )

17.38 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 17.38
Bid (Size) 17.10 (1)
Ask (Size) 18.18 (1)
Prev. Close 17.38
Today's Range 17.38 - 17.38
52wk Range 15.12 - 43.00
Shares Outstanding 66,295,508
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Kura Oncology to Participate in Two Upcoming Investor Conferences
From GlobeNewswire News Releases
PepGen Announces New Additions to Leadership Team and Board of Directors
From GlobeNewswire News Releases

Performance

YTD
-48.90%
-48.90%
1 Month
-17.24%
-17.24%
3 Month
-4.61%
-4.61%
6 Month
-38.56%
-38.56%
1 Year
-42.60%
-42.60%

More News

Read More
Kura Oncology Reports Second Quarter 2021 Financial Results
From GlobeNewswire News Releases
Kura Oncology to Participate in Wedbush PacGrow Healthcare Virtual Conference
From GlobeNewswire News Releases
Jon Najarian Sees Unusual Options Activity In Lucid Motors, Kura Oncology And More
Tags Jon Najarian Small Cap Benzinga
From Benzinga
First Week of April 2022 Options Trading For Kura Oncology
Tags Stocks
From Market News Video
Understanding Kura Oncology's Unusual Options Activity
Tags KURA BZI/UOA Movers
From Benzinga
Kura Oncology, inc (KURA) Q2 2021 Earnings Call Transcript
Tags Market News KURA
From Motley Fool
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Tags TRIL FGEN GRPH
From Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Tags FGEN AKYA ISRG
From Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Tags VYNE MOR ABVC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.